자료유형 | 단행본 |
---|---|
서명/저자사항 | Multiple sclerosis : questions and answers for patients and loved ones/ Jonathan Howard, MD. [electronic resource]. |
개인저자 | Howard, Jonathan,1975- author. |
발행사항 | New York: Demos Health, 2019. |
형태사항 | 1 online resource. |
기타형태 저록 | Print version: Howard, Jonathan, 1975- author. Multiple sclerosis New York : Demos Health, 2019 9780826177469 |
ISBN | 9780826177476 0826177476 |
서지주기 | Includes bibliographical references and index. |
내용주기 | Cover; Title; Copyright; Contents; Preface; Acknowledgments; Share Multiple Sclerosis: Questions and Answers for Patients and Loved Ones; Chapter 1: An Introduction to MS; 1. What Are the Worst Symptoms for Newly Diagnosed Patients?; 2. What Is MS?; 3. Neuroscience Basics; 4. What Happens in MS?; 5. What Causes MS?; 6. How Is MS Diagnosed?; 7. Do I Need a Lumbar Puncture?; 8. What Should I Expect With a Lumbar Puncture?; 9. What Are the Initial Symptoms of MS?; 10. What Is a Relapse?; 11. What Are the Stages and Different Types of MS?; 12. How Can I Tell What Stage of MS I'm in? 13. What Is the Prognosis of MS?14. What Is the Life Expectancy for People With MS?; 15. Will I Wake up One Day and Not Be Able to Walk?; 16. Do Relapses Matter?; 17. What About Pediatric MS?; Chapter 2: The MRI and MS; 18. What Is an MRI and What Does It Show in MS?; 19. How Are MRIs Used to Diagnose MS?; 20. How Do MRIs Help With Relapses?; 21. How Do MRIs Help With Disease Surveillance?; 22. Do All White Spots Mean MS?; Chapter 3: Treating MS Part I: Relapses; 23. How Are Relapses Treated?; 24. What Are the Side Effects of Steroids?; 25. Are There Options Besides Steroids for Relapses? 26. What Is ACTHAR?27. What Is Plasmapheresis?; Chapter 4: Treating MS Part II: Disease-Modifying Therapies; 28. What Are the Disease-Modifying Therapies?; 29. How Do We Evaluate the Medications for MS?; 30. What Is the EDSS?; 31. Why Is MS a Difficult Disease to Study?; 32. Why Should I Take a Medication if I Feel Fine?; 33. Which Medicine Should I Start Taking?; 34. What Are Monoclonal Antibodies?; 35. What Is Tysabri (natalizumab)?; 36. What Are the Risk Factors for PML in Patients on Tysabri?; 37. How Is PML Diagnosed?; 38. Can PML Be Treated?; 39. What Is Lemtrada (alemtuzumab)? 40. What Is Ocrevus (ocrelizumab)?41. What About the Oral Medications?; 42. What Is Gilenya (fingolimod)?; 43. What Are the Downsides to Gileyna?; 44. What Is Aubagio (teriflunomide)?; 45. What Is Tecfidera (dimethyl fumarate)?; 46. PML Summary; 47. What Is Novantrone (mitoxantrone)?; 48. How Do I Know if My Medication Is Working?; 49. What Is Dangerous for Patients with MS?; 50. Will I Have to Take This Medication for the Rest of My Life?; 51. Can Medications Be Combined?; 52. What About Stem Cells?; 53. What About Treating Pediatric MS?; 54. Why Is Progress in MS So Difficult? 55. Should I Take Any Supplements?56. What About Vitamin D?; 57. What About Biotin?; 58. What About "Cure-Alls" in MS?; Chapter 5: Treating MS Part III: Symptoms; 59. What Are Symptomatic Treatments for MS?; 60. What About Marijuana?; 61. What Is Polypharmacy?; 62. What Is the Role of Physical Therapy in MS?; 63. What Is the Role of Occupational Therapy in MS?; 64. What Mobility Assistive Devices Are Available?; Chapter 6: Lifestyle and MS; 65. What Lifestyle Changes Should I Make?; 66. What Is the Best Thing I Can Do for My Health?; 67. Should I Change My Diet? |
일반주제명 | Multiple sclerosis --Popular works. Multiple sclerosis --Treatment --Popular works. Multiple sclerosis --Miscellanea. Multiple sclerosis. Multiple sclerosis --Treatment. HEALTH & FITNESS / Diseases / General. MEDICAL / Clinical Medicine. MEDICAL / Diseases. MEDICAL / Evidence-Based Medicine. MEDICAL / Internal Medicine. |
언어 | 영어 |
바로가기 |